Low-Cost Generic Cardiovascular Drugs

Dr. Centor discusses the current increase in cases of dengue with Drs. Davidson Hamer and Ralph Huits.

Dr. Centor discusses the adverse events associated with checkpoint inhibitors with Drs. Reaford Blackburn Jr. and Brian C. Westbrook.

Dr. Centor discusses how to go beyond statistical significance testing when interpreting study findings with Dr. David Savitz.

Dr. Centor discusses the real-world complications of lung cancer screening with Drs. Katharine A. Rendle and Anil Vachani.

Dr. Centor discusses the association between gabapentinoids and chronic obstructive pulmonary disease with Mr. Rahman and Dr. Renoux.

Dr. Centor discusses encouraging patients to receive influenza vaccination with Drs. Mark Tenforde and Fatimah Dawood.

Dr. Centor discusses balancing clinical demands with the educational mission in academic hospital medicine programs with Drs. Marisha Burden and Vishruti Patel.

Dr. Centor discusses rebound of COVID-19 after treatment with nirmatrelvir-ritonavir with Dr. Myron Cohen.

Dr. Centor discusses the availability of recommended cardiovascular drugs in low-cost generic drug programs with Dr. Cynthia Jackevicius.

Dr. Centor discusses suspected bronchiectasis and mortality in people who smoke with and without normal lung function with Dr. Alejandro Diaz.